Cubpopulyatsionnyy sostav i tsitokinsekretornaya funktsiya kletok produkta separatsii u bol'nykh limfomami
- 作者: Baranova D1, Sakhno L1, Kryuchkova I1, Pronkina N1, Batorov E1, Tikhonova M1, Gilevich A1, Sergeevicheva V1, Sizikova S1, Ushakova G1, Ostanin A1, Pospelova T2, Chernykh E1
-
隶属关系:
- ФГБУ НИИ клинической иммунологии СО РАМН, Москва
- Новосибирский государственный медицинский университет
- 期: 卷 14, 编号 2 (2012)
- 页面: 14-19
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29482
- ID: 29482
如何引用文章
全文:
详细
作者简介
D Baranova
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
L Sakhno
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
I Kryuchkova
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
N Pronkina
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
E Batorov
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
M Tikhonova
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
A Gilevich
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
V Sergeevicheva
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
S Sizikova
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
G Ushakova
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
A Ostanin
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
T Pospelova
Новосибирский государственный медицинский университетНовосибирский государственный медицинский университет
E Chernykh
ФГБУ НИИ клинической иммунологии СО РАМН, МоскваФГБУ НИИ клинической иммунологии СО РАМН, Москва
参考
- Porrata LF. Clinical evidence of autologous graft versus tumor effect. Am J Immunol 2009; 5: 1-7.
- Porrata LF, Litzow MR, Markovic SN. Graft engineering for autologous stem cell transplantation. Gene Therapy and Molecular Biology 2005; 9: 121-34.
- Atta EH, de Azevedo AM, Maiolino A et al. High CD8+ lymphocyte dose in autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation. Am J Hematol 2009; 84: 21-8.
- Hiwase DK, Hiwase S, Bailey M et al. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2008; 14: 116-24.
- Kim DG, Won DI, Lee NY et al. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 719-28.
- Schmidmaier R, Oversohl N, Schnabel B et al. Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients. Exp Oncol 2008; 30 (3): 240-3.
- Damiani D, Stocchi R, Masolini P et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplantation 2002; 30: 261-6.
- Dean R, Masci P, Pohlman B et al. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplantation 2005; 36: 1049-52.
- Trébéden-Negre H, Rosenzwajg M, Tanguy M-L et al. Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft. Transfusion 2010; 50 (12): 2649-59.
- Vieweg J, Su Z, Dahm P, Kusmartsev S. Reversal of tumor-mediated immunosuppression. Clin Cancer Res 2007; 13 (Suppl. 2): 727-32.
- Matsuoka K, Kim HT, McDonough S et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010; 120: 1479-93.
- Condomines M, Quittet P, Lu ZY et al. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol 2006; 176: 6631-9.
- Williams K, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol 2007; 19 (5): 318-30.
- Fontenot JD, Rudensky AY. A weel adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp 3. Nature Immunol 2005; 6: 331-7.
- Lizee G, Radvanyi L, Overwijk WW, Hwu P. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms. Clin Cancer Res 2006; 12: 4794-803.
- Tiemessen MM, Jagger AL, Evans HG et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. PNAS 2007; 104: 19 446-51.